Barclays
AHPI

Barclays’s Allied Healthcare Products AHPI Stock Holding History

Barclays’s Portfolio AHPI Stock Details AHPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,574
Closed -$37K – 5331
2020
Q4 		$37K Buy
+7,574
New +$38.9K ﹤0.01% 4537
2020
Q3 		– Sell
-19,600
Closed -$231K – 5723
2020
Q2 		$231K Buy
+19,600
New +$233K ﹤0.01% 3956

Other funds holding AHPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays's AHPI Position: Q1 2021 in Review

Barclays sold out of Allied Healthcare Products (AHPI) in Q1 2021, closing a stake of 7,574 shares — an estimated $37K sold.

Barclays first reported a position in AHPI in Q2 2020 and held it in 2 quarters. The position peaked at $231K in Q2 2020. 15 funds tracked by Wall St. Rank hold AHPI as of Q1 2021.

  • Barclays reported no remaining Allied Healthcare Products position as of Q1 2021 after selling out during the quarter.
  • Barclays sold 7,574 Allied Healthcare Products shares in Q1 2021, an estimated $37K.
  • Barclays first reported a position in Allied Healthcare Products in Q2 2020 and held it in 2 quarters.
  • Barclays's Allied Healthcare Products position peaked at $231K in Q2 2020.
  • 15 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q1 2021.

Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.